Replimune Group, Inc. (REPL) is a publicly traded Healthcare sector company. As of July 14, 2026, REPL trades at $10.00 with a market cap of $922.56M and a P/E ratio of -2.96. REPL moved -9.55% today. Year to date, REPL is +1.17%; over the trailing twelve months it is -9.43%. Its 52-week range spans $1.50 to $17.00. Analyst consensus is neutral with an average price target of $14.00. Rallies surfaces REPL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest REPL news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $10.00 |
| Market Cap | $922.56M |
| P/E Ratio | -2.96 |
| EPS | $-3.38 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.00 |
| 52-Week Low | $1.50 |
| Volume | 2.65M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-313.94M |
| Gross Margin | 0.00% |
5 analysts cover REPL: 0 strong buy, 2 buy, 2 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $14.00.